Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.P900032-JLR200 on May 24, 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
P900032-JLR200v1
50/11/2314    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marfella, R.
Right arrow Articles by Paolisso, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marfella, R.
Right arrow Articles by Paolisso, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 50, 2314-2323, November 2009
Copyright © 2009 by American Society for Biochemistry and Molecular Biology


Patient-Oriented and Epidemiological Research

Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome[S]

Raffaele Marfella1,2,*, Clara Di Filippo1,{dagger}, Michele Portoghese§, Michelangela Barbieri*, Franca Ferraraccio**, Mario Siniscalchi*, Federico Cacciapuoti*, Francesco Rossi{dagger}, Michele D'Amico{dagger} and Giuseppe Paolisso*

* Department of Geriatrics and Metabolic Diseases, Second University of Naples, Italy
{dagger} Department of Experimental Medicine, Second University of Naples, Italy
** Department of Preventive Medicine, Second University of Naples, Italy
§ Cardiovascular Surgery Unit, Sassari Hospital, Sassari, Italy

2 To whom correspondence should be addressed. e-mail: raffaele.marfella{at}unina2.it

We evaluated the role of sterol-regulatory element binding protein (SREBP)-1c/peroxisome proliferator activated receptor-{gamma} (PPAR{gamma}) pathway on heart lipotoxicity in patients with metabolic syndrome (MS) and aortic stenosis (AS). Echocardiographic parameters of heart function and structural alterations of LV specimens were studied in patients with (n = 56) and without (n = 61) MS undergoing aortic valve replacement. Tissues were stained with hematoxylin-eosin (H and E) and oil red O for evidence of intramyocyte lipid accumulation. The specimens were also analyzed with PCR, Western blot, and immunohistochemical analysis for SREBP-1c and PPAR{gamma}. Ejection fraction (EF) was lower in MS compared with patients without MS (P < 0.001); no difference was found in aortic orifice surface among the groups. H and E and oil red O staining of specimens from MS patients revealed several myocytes with intracellular accumulation of lipid, whereas these alterations were not detected in biopsies from patients without MS. Patients without MS have low levels and weak immunostaining of SREBP-1c and PPAR{gamma} in heart specimens. In contrast, strong immunostaining and higher levels of SREBP-1c and PPAR{gamma} were seen in biopsies from the MS patients. Moreover, we evidenced a significative correlation between both SREBP-1c and PPAR{gamma} and EF and intramyocyte lipid accumulation (P < 0.001). SREBP-1c may contribute to heart dysfunction by promoting lipid accumulation within myocytes in MS patients with AS; SREBP-1c may do it by increasing the levels of PPAR{gamma} protein.

Supplementary key words aortic stenosis • heart function • surgery

Abbreviations: apM1, adipose most-abundant gene transcript 1; AS, aortic stenosis; BMI, body mass index; EF, ejection fraction; H and E, hematoxylin-eosin; HF, heart failure; HOMA, homeostasis model assessment; HPRT, hypoxanthine-phosporybosil transferase; LV, left ventricular; MDA, malondialdehyde; MPI, myocardial performance index; MS, metabolic syndrome; PPAR, peroxisome proliferator activated receptor; SERCA, sarco-endoplasmic reticulum ATPase; SREBP, sterol-regulatory element binding protein; WC, waist circumference


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
R. Harmancey, C. R. Wilson, N. R. Wright, and H. Taegtmeyer
Western diet changes cardiac acyl-CoA composition in obese rats: a potential role for hepatic lipogenesis
J. Lipid Res., June 1, 2010; 51(6): 1380 - 1393.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. C. Schulze
Myocardial lipid accumulation and lipotoxicity in heart failure
J. Lipid Res., November 1, 2009; 50(11): 2137 - 2138.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement